AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT02152462 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Exergaming
Description: The participants in the Wii Fit exergaming group will be encouraged to meet and then maintain a goal of 150 min/wk of moderate intensity exercise for 6 months. Goals per individual will be based on their baseline data. Exercise duration will increase gradually from 75 min/wk at week 1 to 150 min/wk by week 4. Thereafter, women will maintain >150 min/wk of moderate-intensity physical activity. The training will consist of 3 days/wk of supervised physical activity using Nintendo Wii Fit active videogames.
Study NCT01505361 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Lactobacillus salivarius PS2
Description: 9 log10 (colony-forming units), freeze-dried powder, daily for 30 week of pregnancy until birth
Study NCT01505361 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Excipient (milk powder)
Description: 100 mg/once a day from 30 week of pregnancy until birth
Study NCT04091802 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: interdental papilla reconstruction with L-PRF
Description: interdental papilla reconstruction with single layer of L-PRF versus multiple layers of L-PRF
Study NCT03012659 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Contraceptive Counseling Training
Description: Intervention sites will receive:~1. In person training: All staff at an intervention health center will participate in a one-day counseling training.~2. On-site shadowing: Trainers will shadow staff in-clinic the day following the training to observe the counseling implementation and provide additional coaching and support.~3. Technical assistance: A Planned Parenthood clinic operations expert will provide follow-up technical assistance.
Study NCT02555319 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transcatheter Pulmonary Valve (TPV)
Description: Transcatheter Pulmonary Valve Replacement
Study NCT03239977 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Online Social Intelligence Training
Description: The SII consists of short 5-10 minute sessions organized into 7 modules designed to raise awareness of human nature and social relationships. The approach is based on evidence that SII is best advanced through interventions that modify key social cognitions regarding social engagement and enhance efficacy expectations regarding performance in social situations.
Study NCT03239977 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Attention Control (AC)
Description: A placebo condition delivered online to both custodial grandmothers and their adolescent grandchild which presents health-related information only.
Study NCT04233138 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: SUPPORT online platform for people with type 1 diabetes
Description: All participants accepting the SUPPORT study will receive the full intervention for 6 months. Their learning is individualized depending on the way they take their insulin (injection or pump) and the way they measure their blood sugar (finger prick or continuous glucose monitoring).~The training program starts with mandatory module on hypoglycemia. Once completed, participants will unlock all level 1 (out of 3 levels) modules from the 6 categories (medication, blood sugar monitoring, nutrition, physical activity, hypo- and hyperglycemia, health and other situations). The platform contains functionalities such as discussion forum, quizzes, videos, downloadable forms, etc. During the first 6 months, participants will receive a bi-weekly newsletter to inform them about what's new on the platform.
Study NCT00546910 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Atomoxetine
Description: A one-week atomoxetine treatment period with the 0.5 mg/kg per day lead-in dose will be succeeded by a 7 week period at the target dose of 1.2 mg/kg per day. 3 capsules of study medication have to be taken once daily in the morning, with or without food.
Study NCT00546910 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 3 capsules of placebo have to be taken once daily in the morning, with or without food.
Study NCT04490226 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Beta-Hydroxybutyrate as Ca-Mg-salt, active
Description: 24 hour intervention with ketone body supplements additional to a normal diet (isocaloric diet in total) to induce ketosis (exogenous ketone bodies), in a metabolic chamber at physical activity level of 1.6, after one day of isocaloric diet in a metabolic chamber at physical activity level of 1.6.
Study NCT04490226 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: ketogenic diet (KetoCal® 4:1 Neutral, Nutricia GmbH, Erlangen, Germany), active
Description: 24 hour interventions with ketogenic isocaloric diet to induce ketosis (endogenous ketone bodies), in a metabolic chamber at physical activity level of 1.6, after one day of isocaloric diet in a metabolic chamber at physical activity level of 1.6.
Study NCT02206542 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Upper limb rehabilitation robot
Description: Upper limb rehabilitation robot is to carry out passive shoulder joint movements including shoulder flexion, shoulder abduction, shoulder horizontal-abduction and shoulder rotation.
Study NCT02206542 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Physical therapy
Study NCT02206542 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Physical therapy
Study NCT02206542 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Electroacupuncture
Study NCT03212131 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Somapacitan
Description: 3 once-weekly subcutaneous administrations (s.c., under the skin) of somapacitan with a dose of 0.08 mg/kg
Study NCT04648423 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sodium Oxybate
Description: solution for oral administration
Study NCT04648423 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: solution for oral administration
Study NCT03965663 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Vibro-tactile Feedback
Description: The device measures the force between the prosthetic food and the ground. With this signals, vibratators are triggered. The vibrators are housed by the prosthetic socket and stimulate the stump.
Study NCT01519622 — intervention group
Intervention type: OTHER
Intervention: Questionnaire
Description: Questionnaire to be distributed among sick elderly in the community
Study NCT02249286 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Child Centered Nutrition Counseling
Description: The intervention comprises child-centered nutrition counseling for caretakers and support for 'developed' gardens and improved backyard poultry production; whereas the control will only receive the agriculture extension and the existing health and nutrition education in the area
Study NCT02249286 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: no intervention
Description: the control will only receive the agriculture extension and the existing health and nutrition education in the area
Study NCT03665350 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Insulin
Description: Insulin as well as oral anti-diabetic drugs will be prescribed by the responsible physician and/or the diabetologist from each participating site, in conformity with the current guidelines, and the therapeutic target chosen according to patient characteristics.~The choice of anti-diabetic medications should be guided by medical needs of each patient and taking into consideration their general safety profile.
Study NCT03493425 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Carboplatin
Description: Given IV
Study NCT03493425 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carboplatin
Description: Given IV
Study NCT03493425 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Cisplatin
Description: Given IV
Study NCT03493425 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cisplatin
Description: Given IV
Study NCT02206542 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Electroacupuncture
Study NCT03691181 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Ventilation
Description: monitoring with the use of the Life2000 Ventilation System for a period of six months
Study NCT02615314 — intervention group
Intervention type: PROCEDURE
Intervention: Particle re-positioning maneuver
Description: Patients with posterior canal BPPV (PC-BPPV) were treated with Epley maneuver. Patients with superior canal (SC-BPPV) were treated with Li or reverse Epley maneuver. Patients with lateral canal (LC) apogeotropic or geotropic nystagmus were treated with Barbeque, Semont's or Gufoni maneuvers. If geotropic or ageotropic type nystagmus is equal intensity on both sides. The involved side was determined according to the patient sense of disturbance or lying down positioning test. If the patient has involvement of both sides according to Dix-Hallpike maneuver. Therapeutic maneuver was applied to the more severe side. All patients were re-evaluated at maximum 7 days.
Study NCT00808990 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: BioFemale
Description: BioFemale 6 months.
Study NCT02902432 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Endostar
Description: The patients will be randomized to CRT arm and CRT+Endostar arm. All patients will receive one cycles of induction chemotherapy, intensity modulated radiation therapy (IMRT) with weekly cisplatin and 3 cycles of chemotherapy after IMRT.
Study NCT04490226 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: fasting, active
Description: 36 hours of fasting, in a metabolic chamber at physical activity level of 1.6, after one day of isocaloric diet in a metabolic chamber at physical activity level of 1.6.
Study NCT01872819 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: antitumor drug screening assay
Description: Undergo high throughput drug sensitivity assay
Study NCT01872819 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: chemotherapy
Description: Patients receive 1 of 160 possible interventions
Study NCT01872819 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: biological therapy
Description: Patients receive 1 of 160 possible interventions
Study NCT03493425 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Docetaxel
Description: Given IV
Study NCT03493425 — intervention group
Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: Image Guided Radiation Therapy
Description: Undergo image guided IMRT
Study NCT03493425 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Image Guided Radiation Therapy
Description: Undergo image guided IMRT
Study NCT03493425 — intervention group
Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: Intensity-Modulated Radiation Therapy
Description: Undergo image guided IMRT
Study NCT03493425 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Intensity-Modulated Radiation Therapy
Description: Undergo image guided IMRT
Study NCT03493425 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Laboratory Biomarker Analysis
Description: Correlative studies
Study NCT03493425 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Laboratory Biomarker Analysis
Description: Correlative studies
Study NCT04490226 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: fasting, inactive
Description: 36 hours of fasting, in a metabolic chamber at physical activity level of 1.3, after one day of isocaloric diet in a metabolic chamber at physical activity level of 1.3.~The same intervention is reproduced one week later.
Study NCT00243399 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oxandrolone
Description: Subjects will be started on a dose of oxandrolone 0.04 mg/kg/day orally, once/day. After 16 weeks, patients will be assessed for hematologic improvement. If this criteria is not met after 16 weeks, the dose will be escalated to 0.08 mg/kg/day. If no improvement is noted after 16 weeks on the escalated dose, oxandrolone therapy will be discontinued.
Study NCT03646006 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bupivacaine
Description: 10 mL (5mg/mL)
Study NCT03646006 — intervention group
Intervention type: DRUG
Group type: SHAM_COMPARATOR
Intervention: Placebo
Description: 10 mL normal saline
Study NCT03038399 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vamorolone 0.25 mg/day/day
Description: Oral administration of 0.25 mg/kg/day daily for 24 months.
Study NCT03038399 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vamorolone 0.75 mg/day/day
Description: Oral administration of 0.75 mg/kg/day daily for 24 months.
Study NCT03038399 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vamorolone 2.0 mg/day/day
Description: Oral administration of 2.0 mg/kg/day daily for 24 months.
Study NCT03038399 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vamorolone 6.0 mg/day/day
Description: Oral administration of 6.0 mg/kg/day daily for 24 months.
Study NCT00143936 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Low- Carbohydrate -Atkins Diet
Description: Low Carbohydrate Diet
Study NCT00143936 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Low Calorie Diet
Description: Maintain a low calorie diet
Study NCT04107129 — intervention group
Intervention type: PROCEDURE
Intervention: Endometrial Biopsy
Description: An endometrial biopsy is the removal of a small piece of tissue from the endometrium, which is the lining of the uterus. Endometrial tissue will be tested for BCL6 and SIRT1 Biomarkers
Study NCT04107129 — intervention group
Intervention type: OTHER
Intervention: Euploid embryo transfer
Description: Patients undergoing IVF and Preimplantation genetic testing will undergo delayed euploid frozen embryo transfer per clinical protocol and standard of care.
Study NCT04328870 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: oxytocin and spinal anesthesia
Description: start oxytocin 10 IU/200 ml saline at the insertion of the spinal anesthesia
Study NCT04328870 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: General anesthsia
Description: General anesthesia alone.
Study NCT03490409 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Thigh compression stocking
Description: Thigh compression stocking
Study NCT01533649 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Andrews/Reiter approach to epilepsy
Description: The Andrews/Reiter approach to epilepsy is a systematic semi-directive, multi-modal counseling intervention that integrates conventional therapies, educational modules, psychological interventions and relaxation techniques in order to assist the individual in improving self-defined life quality. Face-to-face counseling sessions and supervision with telephone calls are based on a standardized workbook (Taking Control of Your Epilepsy) as an on-going step-by-step guideline.
Study NCT01533649 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Relaxation/Meditation
Description: Subjects who participate in the relaxation control group will attend weekly relaxation sessions that will employ the following relaxation techniques: meditation, progressive muscle relaxation, autogenic training.
Study NCT04224194 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: OTHER
Intervention: Adalimumab
Description: Combined product as Drug is delivered through an autoinjector pen on which real-life patient handling experience is assessed.
Study NCT01104428 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: granules, \<10years,10g,Three times a day,take orally >10years,20g,Three times a day,take orally fore weeks a period,Observe 2 periods
Study NCT01104428 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ziying granules
Description: granules, \<10years,10g,Three times a day,take orally >10years,20g,Three times a day,take orally fore weeks a period,Observe 2 periods
Study NCT03370107 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: rTMS
Description: Conventional magnetic stimulations will be applied with a MacPROX100 machine using neuronavigation system. H-coil rTMS will be delivered with the Brainsway H-coil (Brainsway, Jerusalem, Israel) applied via a helmet placed on the head corresponding to the primary motor cortex (H10 coil) and connected to a Masgtim Rapid2 stimulatior (Mastim, Whitland, UK), while sham stimulation will be delivered with a sham coil placed in the helmet encasing the active rTMS coil. Active rTMS sessions with H-coil will use exactly the same parameters of stimulation as conventional rTMS.
Study NCT03370107 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: rTMS
Description: Conventional magnetic stimulations will be applied with a MacPROX100 machine using neuronavigation system. H-coil rTMS will be delivered with the Brainsway H-coil (Brainsway, Jerusalem, Israel) applied via a helmet placed on the head corresponding to the primary motor cortex (H10 coil) and connected to a Masgtim Rapid2 stimulatior (Mastim, Whitland, UK), while sham stimulation will be delivered with a sham coil placed in the helmet encasing the active rTMS coil. Active rTMS sessions with H-coil will use exactly the same parameters of stimulation as conventional rTMS.
Study NCT03998709 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Somatostatin
Description: Somatostatin will be used to inhibit endogenous insulin secretion on either study day in both arms of the study
Study NCT03998709 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Dextrose
Description: intravenous glucose will be used to raise fasting glucose in people with NFG / NGT
Study NCT03998709 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Insulin
Description: insulin will be used to lower fasting FFA and glucose in people with IFG / IGT
Study NCT03998709 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Intralipid
Description: intravenous intralipid (Fat Emulsion) will be used to raise fasting FFA in people with NFG / NGT
Study NCT02008643 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: filling questionnary to quality of life
Description: filling questionnary to quality of life
Study NCT02008643 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: filling questionnary to quality of life
Description: filling questionnary to quality of life
Study NCT03493425 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Questionnaire Administration
Description: Ancillary studies
Study NCT00787150 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Apixaban
Description: Apixaban 5 mg tablet BID for 12 weeks
Study NCT00787150 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Apixaban
Description: Apixaban 2.5 mg tablet BID for 12 weeks
Study NCT03493425 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Questionnaire Administration
Description: Ancillary studies
Study NCT03493425 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Therapeutic Conventional Surgery
Description: Undergo standard of care surgery
Study NCT00787150 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Warfarin sodium
Description: At each visit, the subject to take appropriate Warfarin tablet (on investigator's order) once a day every morning for 12 weeks
Study NCT03493425 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Therapeutic Conventional Surgery
Description: Undergo standard of care surgery
Study NCT03571620 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Q301 Cream
Description: 1.0% or 1.4% Q301 Cream
Study NCT03571620 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Vehicle
Description: Vehicle Control
Study NCT01601054 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Tantalum cage from Zimmer
Description: A tantalum cage will be inserted through a left sided retroperitoneal approach
Study NCT03194152 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Peanut
Description: Dietary Supplement: Peanut
Study NCT03194152 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Control
Description: Dietary Supplement: High carbohydrate snacks
Study NCT02524860 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Focal-Fusion Bx
Description: The Focal-Fusion Bx device uses hardware and software to overlay targets onto the live ultrasound image in real-time. This allows the urologist to take biopsy samples from tissue that looked suspicious on the patient's MRI.
Study NCT03591679 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Oxytocin
Description: 20 units by slow intravenous drip injection
Study NCT04695665 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Cervical pain
Description: Exercise program for cervical spine according to McGill's approach.
Study NCT04695665 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Thoracic pain
Description: Exercise program for thoracic spine according to McGill's approach.
Study NCT04695665 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Lumbar pain
Description: Exercise program for lumbar spine according to McGill's approach.
Study NCT00867139 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TCAD
Description: TCAD (amantadine hydrocholoride, ribavirin and oseltamivir phosphate)
Study NCT00867139 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Zanamivir or Oseltamivir
Description: Zanamivir or Oseltamivir
Study NCT00867139 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Open label treatment with TCAD
Description: TCAD(amantadine hydrocholoride, ribavirin and oseltamivir phosphate)